Medipharm Labs Corporation (OTCMKTS:MEDIF) has announced the expansion of its innovative Pharma-quality family branded products with the launch of THC 30, CBD 100, and its first cannabinoid cannabinol (CBN) rich formula.
MediPharm creating CBD products for wellness and medical needs
Keith Strachan, the company’s interim CEO, said that MediPharm is dedicated to creating customized innovative products that customers can trust for wellness and medicinal needs. Strachan said that the release of new CBD formulas, including the first minor cannabinoid CBN formulation, enables the company to fill the growing consumer need for more customized products while maintaining the commitment to pharma-quality production.
These new products are MediPharm’s latest in its branded products family, and each delivers a unique flavor profile from the naturally occurring cannabis terpenes. Each uses palm/coconut-based MCT carrier oil carefully picked for sustainable practices, and each produced as per the company’s manufacturing standards to maintain the highest quality and purity. The products include THC30 formula oil, which contains 30mg/ml, and CBD100 Ultra formula oil, which contains the highest CBD available at 100g/ml.
Similarly, MediPharm Labs launched next-generation oil products with the first CBN formula. CBN1:2 Nighttime Formula contains 10mg/ml of CBN and 20mg/ml of THC, and it employs full-spectrum cannabis concentrate CBN.
CBN available in traces in cannabis but can be oxidized
CBN is usually available in cannabis plants in trace quantities but can be produced through THC oxidation. It binds to endocannabinoid CB1 receptors just like THC, but its binding is 8-10 times less strong, leading to less psychoactive effects than the same THC dose.
Patients can access initial quantities in the coming weeks through Medical Cannabis by Shoppers™. However, consumers can access through retail channels in Alberta, Manitoba, British Columbia, Saskatchewan, and Ontario. The company expects to attain full national distribution of the full suite of cannabis products to be a “One-Stop-Shop” for distributors and retailers across the country. The company is known to process, package, test, and distribute cannabis concentrates and advanced CBD-based products for the Canadian by leveraging its white label and wholesale platforms.
Sundial Growers Inc (NASDAQ:SNDL) Inks An Equity Sale Accord With ATB Capital Markets And Canaccord Genuity To Raise Maximum Of $800 Million: Reports $13.9 Million In Revenues In Q4 2020
Post Views: 248 Sundial Growers Inc (NASDAQ:SNDL) inked a stock sale agreement with ATB Capital Markets and Canaccord Genuity agents....
High Tide Inc (OTCMKTS:HITIF) Posts Impressive Growth Of 17% In Revenues In Q1 2021
Post Views: 582 High Tide Inc (OTCMKTS:HITIF) reported revenues of $38.3 million (up 179% YoY) in Q1 2021. It included...
Heritage Cannabis Holdings Corp (OTCMKTS:HERTF) Reports CAD 1.827 Million Revenues In Q1 2021
Post Views: 280 Heritage Cannabis Holdings Corp (OTCMKTS:HERTF) reported revenues of CAD 1.827 million (down 54.41% YoY) in Q1 2021....
Cresco Labs Inc (OTCMKTS:CRLBF) Reports Revenues Of $162.3 Million In Q4 2020: Adjusted EBITDA Increases 8% To $50 Million in Q4 2020
Post Views: 306 Cresco Labs Inc (OTCMKTS:CRLBF) reported a growth of 6% QoQ to $162.3 million in Q4 2020. Its...
Tauriga Sciences Inc (OTCMKTS:TAUG) Inks A Pact With Coalition Technologies To Improve SEO Metrics: Converts US PPA To Non US PPA
Post Views: 330 Tauriga Sciences Inc (OTCMKTS:TAUG) signed an agreement with Coalition Technologies to enhance its SEO (search engine optimization)...
Medipharm Labs Corporation (OTCMKTS:MEDIF) Expands Its Innovative Branded Products Line With Launch Of New Formulations
Post Views: 367 Medipharm Labs Corporation (OTCMKTS:MEDIF) has announced the expansion of its innovative Pharma-quality family branded products with the...